Struma Ovarii
|
disease |
Neoplasms
|
Neoplastic Process
|
10
|
1
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Mammary Analogue Secretory Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
17
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Spindle Cell Neoplasm
|
disease |
|
Neoplastic Process
|
19
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Mixed follicular and papillary thyroid carcinoma
|
disease |
|
Neoplastic Process
|
31
|
8
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Follicular Variant Thyroid Gland Papillary Carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
36
|
13
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Salivary duct carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
54
|
9
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Multiple Endocrine Neoplasia Type 2a
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
69
|
44
|
0.010 |
None |
1.000 |
1 |
|
1995 |
1995 |
Substance Withdrawal Syndrome
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
80
|
5
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Alopecia, Male Pattern
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
91
|
743
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Androgenetic Alopecia
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
112
|
107
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Thyroid Nodule
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
150
|
17
|
0.030 |
None |
1.000 |
3 |
|
2002 |
2015 |
Autoimmune thyroiditis
|
disease |
Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
161
|
76
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
androgen independent prostate cancer
|
disease |
|
Neoplastic Process
|
190
|
5
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Thyroid Gland Follicular Adenoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
202
|
14
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Carcinoma, Papillary
|
disease |
Neoplasms
|
Neoplastic Process
|
225
|
9
|
0.090 |
None |
0.889 |
9 |
|
1997 |
2005 |
Thyroid Diseases
|
group |
Endocrine System Diseases
|
Disease or Syndrome
|
230
|
26
|
0.020 |
None |
1.000 |
2 |
|
2005 |
2011 |
Anaplastic carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
232
|
3
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Iron Overload
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
241
|
53
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2019 |
Mean Corpuscular Volume (result)
|
phenotype |
|
Laboratory or Test Result
|
269
|
549
|
0.100 |
None |
1.000 |
2 |
1
|
2017 |
2018 |
Papilloma
|
disease |
Neoplasms
|
Neoplastic Process
|
273
|
27
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Nodule
|
phenotype |
|
Acquired Abnormality
|
278
|
19
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Undifferentiated carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
283
|
8
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Hashimoto Disease
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
335
|
131
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Benign Neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
371
|
7
|
0.010 |
None |
< 0.001 |
1 |
|
2001 |
2001 |
Anaplastic thyroid carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
392
|
16
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |